HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc Stock Analysis & Ratings

TSE:HLS Stock Chart & Stats

Day’s RangeC$12.59 - C$12.67
52-Week RangeC$11.98 - C$20.52
Previous CloseC$12.5
Volume2.70K
Average Volume (3M)11.09K
Market CapC$411.37M
P/E Ratio-26.9
Beta0.29
Next EarningsAug 11, 2022
Dividend Yield0.16 (1.6%)
Smart Score7
EPS (TTM)-0.46


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

TSE:HLS FAQ

What was HLS Therapeutics Inc’s price range in the past 12 months?
HLS Therapeutics Inc lowest stock price was C$11.98 and its highest was C$20.52 in the past 12 months.
    What is HLS Therapeutics Inc’s market cap?
    HLS Therapeutics Inc’s market cap is C$411.37M.
      What is HLS Therapeutics Inc’s price target?
      The average price target for HLS Therapeutics Inc is C$29.88. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is C$36.00 ,the lowest forecast is C$26.50. The average price target represents 135.83% Increase from the current price of C$12.67.
        What do analysts say about HLS Therapeutics Inc?
        HLS Therapeutics Inc’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is HLS Therapeutics Inc’s upcoming earnings report date?
          HLS Therapeutics Inc’s upcoming earnings report date is Aug 11, 2022 which is in 83 days.
            How were HLS Therapeutics Inc’s earnings last quarter?
            HLS Therapeutics Inc released its earnings results on May 05, 2022. The company reported -C$0.141 earnings per share for the quarter, missing the consensus estimate of -C$0.122 by -C$0.019.
              Is HLS Therapeutics Inc overvalued?
              According to Wall Street analysts HLS Therapeutics Inc’s price is currently Undervalued.
                Does HLS Therapeutics Inc pay dividends?
                HLS Therapeutics Inc pays a Quarterly dividend of C$0.05 which represents an annual dividend yield of 1.6%. HLS Therapeutics Inc’s last Quarterly dividend payment was on Sep 15, 2022. HLS Therapeutics Inc’s upcoming ex-dividend date is Jul 28, 2022
                  What is HLS Therapeutics Inc’s EPS estimate?
                  HLS Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does HLS Therapeutics Inc have?
                  HLS Therapeutics Inc has 32,470,000 shares outstanding.
                    What happened to HLS Therapeutics Inc’s price movement after its last earnings report?
                    HLS Therapeutics Inc reported an EPS of -C$0.141 in its last earnings report, missing expectations of -C$0.122. Following the earnings report the stock price went down -0.872%.
                      Which hedge fund is a major shareholder of HLS Therapeutics Inc?
                      Currently, no hedge funds are holding shares in TSE:HLS

                      ---

                      HLS Therapeutics Inc Stock Analysis

                      Analyst Forecast

                      Strong Buy
                      Average Price Target: C$29.88

                      Blogger Sentiment

                      Bullish
                      TSE:HLS Sentiment 100% Sector Average 71%

                      Hedge Fund Holdings

                      N/A
                      Currently Not Enough Data Available

                      Insider Transactions

                      ▼ Sold Shares
                      Worth C$594.6K over the Last 3 Months

                      Retail Investors

                      N/A
                      Currently Not Enough Data Available

                      News Sentiment

                      N/A
                      Currently Not Enough Data Available

                      Technicals

                      SMA
                      Negative
                      20 days / 200 days
                      Momentum
                      -24.46%
                      12-Months-Change

                      Fundamentals

                      Return on Equity
                      -7.36%
                      Trailing 12-Months
                      Asset Growth
                      -9.40%
                      Trailing 12-Months
                      The HLS Therapeutics Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      HLS Therapeutics Inc

                      HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada and the United States.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Profound Medical
                      Aurinia Pharmaceuticals
                      Medicenna Therapeutics Corp
                      BELLUS Health

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis